Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 08 Feb 2024 for Laboratory CORP of America Holdings. Read the official filing
Filing timeline
BuySaleR. Sanders Williams
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
R. Sanders Williams: trading record in brief
Filings by R. Sanders Williams span 2 companies, the busiest being Amgen Inc and Labcorp Holdings Inc. In total, 10 filings cover trades dated from 7 May 2021 to 7 February 2024.
Sales make up the whole of the open-market record (4 sales, €385k). Other entries cover 3 share grants and 3 option exercises.
On 8 February 2024 came the latest disclosure, an option exercise in Labcorp Holdings Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to R. Sanders Williams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
947 sharesCommon StockSEC:0001127602-24-003895:0
939 shares0Common StockSEC:0001127602-23-016642:0
742 sharesCommon StockSEC:0001127602-23-005106:0
200 shares@ US$249.9617.0% of flowCommon StockSEC:0001127602-22-021453:0
600 shares@ US$250.000.0001% mcap57.4% of flowCommon StockSEC:0001127602-22-015409:0
855 shares0Common StockSEC:0001127602-22-015182:0
572 shares@ US$272.980.0007% mcap100.0% of flowCommon StockSEC:0001127602-22-010475:0
771 sharesCommon StockSEC:0001127602-22-003272:0
837 shares0Common StockSEC:0001127602-21-017471:0
250 shares@ US$251.7821.5% of flowCommon StockSEC:0001127602-21-016121:0
10 of 10 declarations
